Grown Rogue International (GRUSF) Net Income Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Net Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -14.93% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | -393.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -393.92% |
| Dec 31, 2025 | -483,173,825.05% |
| Sep 30, 2025 | 579,639,028.52% |
| Jun 30, 2025 | 125.64% |
| Mar 31, 2025 | 124.36% |
| Dec 31, 2024 | 188.68% |
| Jan 31, 2023 | 257.71% |
| Jan 31, 2022 | 112.33% |
| Oct 31, 2021 | 716,500,416.60% |
| Jul 31, 2021 | 221.79% |
| Jan 31, 2021 | -527.03% |
| Oct 31, 2020 | -100.73% |
| Jul 31, 2020 | 73.42% |
| Apr 30, 2020 | -26.79% |
| Jan 31, 2020 | -95.14% |
| Oct 31, 2019 | 34.76% |
| Jul 31, 2019 | -450.81% |
| Apr 30, 2019 | 243.24% |
| Jan 31, 2019 | 458.88% |
| May 31, 2018 | 108.36% |